Bernd Fiebich

This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Symrise Ag, Probi Ab. Active years: 2021-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernd Fiebich. Retrieved from https://idiyas.com/inventor/bernd-fiebich

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 (Patent Applications = 1)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 7)

Average Co-Inventor Count = 4.6

ph-index = 1

Company Filing History:

where one patent can have more than one assignee

Years Active: 2021-2022

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11485700 - Synthesis of (+)-cannabinoids and their therapeutic effects (2022-11-01),

2. 11338001 - Probiotics for aggregation with disease-associated species in the oral cavity (2022-05-24),

3. 11020441 - Probiotics for use as anti-inflammatory agents in the oral cavity (2021-06-01),

Title: Bernd Fiebich: Innovator in Therapeutic Compounds and Probiotics

Introduction

Bernd Fiebich is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of therapeutic compounds and probiotics, holding a total of 3 patents. His work focuses on innovative methods for producing compounds that have potential therapeutic effects.

Latest Patents

Fiebich's latest patents include a method for the synthesis of (+)-cannabinoids and their therapeutic effects. This invention relates to producing a compound of formula (I) or a salt of that compound for use in therapeutic methods aimed at treating and preventing certain diseases. Additionally, he has developed a pharmaceutical composition that includes one or more compounds of formula (I). Another significant patent involves probiotics for aggregation with disease-associated species in the oral cavity. This invention focuses on specific microorganisms or mixtures for treating and preventing inflammation, particularly gingivitis and periodontitis. It also provides oral pharmaceutical compositions and products that incorporate these probiotic microorganisms.

Career Highlights

Throughout his career, Bernd Fiebich has worked with prominent companies such as Symrise AG and Probi AB. His experience in these organizations has contributed to his expertise in the development of innovative therapeutic solutions.

Collaborations

Fiebich has collaborated with notable colleagues, including Marcus Rudolf Götz and Kerstin Holmgren. These partnerships have further enhanced his research and development efforts in the field of therapeutics and probiotics.

Conclusion

Bernd Fiebich is a distinguished inventor whose work in therapeutic compounds and probiotics has the potential to impact health and wellness significantly. His innovative patents and collaborations reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.